Forbion
4 rounds tracked since 28 April 2026.
- Rounds
- 4
- Led
- 3
- Capital in these rounds
- $783M
Sectors
Countries
Rounds
- OMass TherapeuticsLead $310MSeries C · 16 Oct
- Sling TherapeuticsLeadDevelops linsitinib, an oral drug for patients with thyroid eye disease. $123MSeries C · 16 Sept
- Solstice OncologyDevelops immunotherapies for earlier treatment of cancer $225MSeries A · 9 Sept
- Coultreon BiopharmaLeadDevelops therapies advancing an immunology drug pipeline. $125MSeries A · 28 Apr
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise